Stem cell therapy takes on lupus and more
NCT ID NCT07301164
First seen Jan 04, 2026 · Last updated May 18, 2026 · Updated 22 times
Summary
This early-phase study tests BCT301, a therapy made from special stem cells turned into immune cells, for people with hard-to-treat autoimmune diseases like lupus and scleroderma. The main goal is to check safety and find the right dose. Only 10 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.